Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2

Affiliations

• ¹ Oregon Medical Research Center, Portland, Oregon, USA. Electronic address: blauveltconsults@gmail.com.
• ² Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
• ³ Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
• ⁴ Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
• ⁵ Janssen Research & Development, LLC, San Diego, California, USA.
• ⁶ Janssen Global Services, LLC, Malvern, Pennsylvania, USA.
• ⁷ Janssen Global Services, LLC, Horsham, Pennsylvania, USA.
• ⁸ Keck School of Medicine, University of Southern California, Los Angeles, California, USA.